Glaxosmithkline



Ebitda Cambiamento Data
AbbVie USD 4.4B 2.52B 2025-03
Amgen USD 3.6B 147M 2025-06
AstraZeneca USD 4.96B 127M 2025-06
Aurora Cannabis CAD -25369000 7.78M 2024-12
Bausch Health Companies USD 912M 315M 2025-06
Bristol-Myers Squibb USD 3.27B 1.63B 2025-06
Canopy Growth CAD -8628000 2.1M 2024-12
Corcept Therapeutics USD 27.14M 23.27M 2025-06
Drreddys Laboratories INR 23.31B 1.4B 2024-12
Eli Lilly USD 7.5B 3.34B 2025-06
GlaxoSmithKline GBP 3.18B 45M 2025-06
Glaxosmithkline GBP 1.69B 1.6B 2024-12
J&J USD 7.88B 1.76B 2025-03
Merck USD 7.74B 625M 2025-03
Novartis USD 6.17B 339M 2025-06
Pacira USD 54.32M 24.98M 2025-06
Perrigo USD 129.1M 1.9M 2025-06
Pfizer USD 5.32B 889M 2025-06
Prestige Brands USD 79.65M 28.5M 2025-06
Roche Holding CHF 12.68B 2.36B 2024-06
Sanofi EUR 1.89B 971M 2025-06
Supernus Pharmaceuticals USD 41.47M 23.68M 2025-06
Takeda JPY 366.2B 238.06B 2025-06
Teva Pharmaceutical Industries USD 1.23B 124M 2025-06
Zoetis USD 1.08B 110M 2025-06


Glaxosmithkline - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.